Group 1 - The core viewpoint of the news is that Huibo New Materials has seen a significant increase in its stock price, rising 1.05% to 32.57 CNY per share, with a total market capitalization of 3.005 billion CNY and a cumulative increase of 8.93% over the past six days [1] - Huibo New Materials specializes in the research, production, and sales of specialty modified epoxy resin products, with the main revenue sources being epoxy resins for wind turbine blades (81.88%), new composite materials (13.74%), and electronic insulation packaging (4.11%) [1] - The company was established on December 15, 2010, and went public on October 31, 2023, indicating a relatively recent entry into the public market [1] Group 2 - According to data, the Fuyong Fund has a significant holding in Huibo New Materials, with the Fuyong Fukan Mixed A Fund increasing its stake by 7,000 shares, now holding a total of 11,700 shares, which represents 2.32% of the fund's net value [2] - The Fuyong Fukan Mixed A Fund has achieved a year-to-date return of 49.69% and a one-year return of 46.81%, ranking 1122 out of 8088 and 1212 out of 8058 respectively in its category [2] - The fund manager, Jiang Fan, has a tenure of 1 year and 187 days, with the best fund return during this period being 49.4% [3]

格隆汇12月24日丨惠柏新材(301555.SZ)在投资者互动平台表示，公司珠海项目(一期)预计2026年一季度 试生产。 ...

东兴证券股份有限公司 关于惠柏新材料科技（上海）股份有限公司 2025 年度现场检查报告 （以下无正文） （本页无正文，为《东兴证券股份有限公司关于惠柏新材料科技（上海）股 份有限公司 2025 年度现场检查报告》之签署页） 保荐代表人：________________ ________________ 保荐机构名称：东兴证券股份有限公司 被保荐公司简称：惠柏新材 保荐代表人姓名：蒋卓征 联系电话：010-66555305 保荐代表人姓名：陆丹彦 联系电话：010-66555305 现场检查人员姓名：蒋卓征 现场检查对应期间：2025 年度 现场检查时间：2025 年 12 月 12 日、12 月 16 日-12 月 17 日 一、现场检查事项 现场检查意见 是 否 不适用 （一）公司治理 现场检查手段：查阅公司章程和现行内部控制制度、治理规则等文件，检查公司三会会议文 件、董事会专门委员会文件；访谈公司相关董事、高级管理人员；查阅公司相关公告及定期 报告等。 1.公司章程和公司治理制度是否完备、合规 √ 2.公司章程和三会规则是否得到有效执行 √ 3.三会会议记录是否完整，时间、地点、出席人员及会议内容等 ...

Group 1 - CICC is planning to absorb and merge Dongxing Securities and Xinda Securities through a share swap, with trading resuming on December 18, 2025 [1] - Victory Energy's major shareholder plans to transfer 29.99% of its shares to Qiteng Robotics, with no plans for asset restructuring in the next 12 months [2] - China Metallurgical Group intends to repurchase A-shares worth 1 to 2 billion yuan at a price not exceeding 4.9 yuan per share [3] Group 2 - Boten Co. plans to acquire part of the Yifeng Yunding Fund for 1 yuan, with a commitment to fulfill a 20 million yuan capital contribution [4] - Tongyou Technology has initiated a 50 million yuan accounts receivable factoring business [5] - Gaode Infrared has received approval to issue debt financing tools totaling up to 3 billion yuan [6] Group 3 - Zhengyu Industrial's application for a private placement of A-shares has been approved by the Shanghai Stock Exchange [7] - China CRRC signed contracts totaling approximately 53.31 billion yuan, accounting for 21.6% of its projected 2024 revenue [9] - High Energy Environment's director increased his stake by purchasing 56,100 shares [10] Group 4 - Shantou Technology received approval from the CSRC for a convertible bond issuance [11] - Puyang Co. plans to use up to 900 million yuan of idle funds for entrusted wealth management [12] - Huibai New Materials has been awarded a government subsidy of 3.8 million yuan, with the first installment of 2.12 million yuan already received [13] Group 5 - Jiayuan Technology's shareholders plan to transfer 2.51% of the company's shares through a pricing inquiry [14] - Lingpai Technology's subsidiary terminated a 125 million yuan procurement contract due to market changes [15] - Juguang Technology intends to use up to 200 million yuan of idle funds for cash management [16] Group 6 - Zhongwen Media's subsidiary terminated a 200 million yuan private equity fund subscription due to market changes [17] - Zhifei Biological's modified vaccine for monkeypox has received clinical trial acceptance [19] - GeKowei's subsidiary received a government subsidy of 60 million yuan, accounting for 32.12% of the company's audited net profit [20] Group 7 - Wantai Biological's application for a clinical trial of a respiratory syncytial virus vaccine has been accepted [21] - Haitai Technology plans to increase capital in its Thai joint venture from 500,000 to 3 million Thai baht [22] - Shanghai Airport signed contracts for the transfer of duty-free store operating rights [23] Group 8 - Del Shares received approval to issue shares for the acquisition of 100% of Aizhuo Intelligent [24] - Novozymes' products have obtained EU CE IVDR certification [25] - Shibai Testing's chairman's assistant plans to increase shareholding by 8 to 12 million yuan [26] Group 9 - Huitian New Materials plans to invest approximately 97.68 million yuan in a lithium battery anode glue project [27] - Pudong Construction's subsidiaries won contracts totaling 1.649 billion yuan [29] - Acolyte's subsidiary has entered trial production for a special high-temperature resistant resin project [30] Group 10 - Pingzhi Information's subsidiary signed a 38.25 million yuan computing power service contract [31] - Tianma Technology is required to pay 5.3625 million yuan in taxes and penalties [32] - Yahon Pharmaceutical's clinical trial application for GLX002 has been approved [34]

Core Viewpoint - 惠柏新材 has been recognized as a "2024 Headquarters Enterprise" in the Hongqiao International Central Business District, which will provide the company with significant financial support from the government [1] Financial Support - The company is expected to receive a one-time headquarters settlement support fund of RMB 1 million and additional functional and scale reward funds totaling RMB 2.8 million, distributed over three years at 40%, 30%, and 30% [1] - The total financial support amounts to RMB 3.8 million [1] - On December 16, 2025, the company received RMB 2.12 million from the Shanghai Jiading District Commerce Committee, which includes RMB 1 million as one-time headquarters settlement support and RMB 1.12 million as functional and scale reward funds [1] Impact on Profit - The government subsidies and related income are expected to account for 47.36% of the company's audited net profit attributable to shareholders for the year 2024 [1]

Group 1 - The company Huibo New Materials (SZ 301555) announced on December 17 that it received a total of RMB 2.12 million from the Shanghai Jiading District Commerce Commission as part of the "Hongqiao Business District Headquarters Enterprise Special Development Fund" [1] - The funding includes a one-time headquarters settlement support fund of RMB 1 million and additional rewards totaling RMB 1.12 million for headquarters functions and scale [1] - For the year 2024, the company's revenue composition is entirely from the chemical industry, accounting for 100% [1] - As of the report date, Huibo New Materials has a market capitalization of RMB 2.8 billion [1]

惠柏新材料科技（上海）股份有限公司 关于公司获得政府补助的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、获取补助的基本情况 根据《虹桥国际中央商务区关于支持总部企业发展的支持政策》及《2024- 2025 年度虹桥国际中央商务区关于支持总部企业发展专项资金申报指南》，经各 区组织推荐、专家评审及虹桥国际中央商务区管委会审定，惠柏新材料科技（上海） 股份有限公司（以下简称"公司"）被认定为"2024 年度虹桥国际中央商务区总 部企业"。根据相关支持政策，公司预计获得一次性总部入驻支持资金人民币 100 万元，以及总部功能奖励资金和总部规模奖励资金人民币 280 万元（该部分资金分 三年按照 40%、30%、30%发放），合计人民币 380 万元。公司于 2025 年 12 月 16 日收到上海市嘉定区商务委员会拨付的"虹桥商务区总部企业专项发展资金"人民 币 212 万元（其中，一次性总部入驻支持资金人民币 100 万元，以及总部功能奖励 资金和总部规模奖励资金 112 万元）。 上述政府补助与收益相关，占公司 2024 年度经审计归属于上市公司股东 ...

东兴证券股份有限公司 （一）保荐机构：东兴证券股份有限公司 （二）保荐代表人：蒋卓征、陆丹彦 （三）培训时间：2025 年 12 月 12 日 （四）培训地点：惠柏新材会议室 （五）培训人员：蒋卓征 （六）培训对象：公司董事、监事、高级管理人员、中层以上管理人员、 控股股东及实际控制人等 关于惠柏新材料科技（上海）股份有限公司 2025年度持续督导培训情况的报告 深圳证券交易所： 东兴证券股份有限公司（以下简称"东兴证券"、"保荐机构"）根据 《深圳证券交易所上市公司自律监管指引第 13 号——保荐业务》《证券发行 上市保荐业务管理办法》对惠柏新材料科技（上海）股份有限公司（以下简称 "惠柏新材"、"公司"）进行了 2025 年度持续督导培训，报告如下： 一、本次持续督导培训的基本情况 （以下无正文） （本页无正文，为《东兴证券股份有限公司关于惠柏新材料科技（上海） 股份有限公司 2025 年度持续督导培训情况的报告》签字盖章页） 保荐代表人： （七）培训内容：关于募集资金使用、信息披露规范、上市公司规范运 作等专项培训，加深了公司董事、高级管理人员对相关法律法规、信息披露、 内部控制要求的理解。 二、上市公 ...

Group 1 - The company Huibai New Materials (SZ 301555) announced the convening of its fourth board meeting on December 12, 2025, to review the proposal for the reappointment of the auditing institution for the fiscal year 2025 [1] - For the year 2024, the company's revenue composition is entirely from the chemical industry, accounting for 100.0% [1] - As of the report date, Huibai New Materials has a market capitalization of 2.9 billion yuan [1]

证券日报网讯 12月12日晚间，惠柏新材发布公告称，公司于2025年12月12日召开第四届董事会第十二 次会议，审议通过了《关于公司为子公司提供担保额度预计的议案》。为满足全资子公司业务发展需 要，2026年度公司拟为全资子公司向银行等金融机构申请综合授信额度提供担保，担保的形式包括但不 限于信用担保（含一般保证、连带责任保证等）、抵押担保、质押担保或多种担保方式相结合等形式， 预计提供担保额度总计不超过人民币6.5亿元，均为资产负债率70%以下的全资子公司提供担保。本次 担保额度预计的有效期限为2026年1月1日至2026年12月31日，在上述有效期限内担保额度可循环使用。 该议案尚需提交公司股东会审议通过。 （文章来源：证券日报） ...